Top colleges defy job gloom as placements rise, salaries climbTop non-engineering undergraduate colleges in India, including St Stephen’s College, Lady Shri Ram College for Women, Loyola College, Chris...
Dabur appoints Hershey’s Herjit Bhalla as India chief; elevates Mohit Malhotra to global roleDabur has appointed Herjit Bhalla, formerly of Hershey, as its new India chief executive, effective April 15. Current chief Mohit Malhotra ...
Haleon Appoints Former Castrol MD Kedar Lele as India Subcontinent PresidentHaleon has appointed Kedar Lele as president, India subcontinent, succeeding Navneet Saluja. Lele, formerly managing director of Castrol In...
Haleon may rope in ex-MD of Castrol India to head local bizHaleon India is reportedly set to appoint Kedar Lele, the outgoing MD of Castrol India, as its new chief early next year. Lele will succeed...
Govt bans select cough syrups for kids below 4 yearsThe government has prohibited cough syrups containing chlorpheniramine maleate and phenylephrine hydrochloride for children under four due ...
Pfizer to cut stake in Sensodyne-maker Haleon to 7.3%, says bookrunnerPfizer is selling around 700 million ordinary shares in Haleon, reducing its stake from 15% to about 7.3%. This sale follows its earlier re...
Dr Reddy's completes acquisition of Haleon's NRT portfolioDr Reddy's Laboratories has acquired Haleon's global Nicotine Replacement Therapy (NRT) portfolio, excluding the US, for GBP 458 million. T...
Dr Reddy's to buy nicotine replacement brands from UK-based Haleon for $632 millionThe portfolio to be acquired consists of Nicotinell, a global leader in the NRT category with an extensive footprint in over 30 countries s...
Glenmark gets USFDA nod to market generic drugGlenmark Pharmaceuticals announced that it has received USFDA approval to market its generic Esomeprazole Magnesium delayed-release capsule...
GSK raises $1.5 billion from sale of remaining Haleon stakeBritish drugmaker GSK has raised 1.25 billion pounds ($1.52 billion) from a sale of its remaining stake in consumer healthcare company Hale...
GSK intends to sell its remaining stake in HaleonGSK, which initially retained a near 13% stake in Haleon, had over the course of a year lowered its stake to 4.2%. Last year, GSK had said ...
Glenmark Pharma gets USFDA nod for generic anti-inflammatory drugGlenmark Pharmaceuticals received USFDA approval for generic Acetaminophen and Ibuprofen tablets. The product, a version of Advil Dual Acti...
Self-care products set to grow big; no downtrading in healthcare, says Haleon CEOAccording to Brian McNamara, the global CEO of consumer healthcare company Haleon, the focus on preventive healthcare post-pandemic is crea...
Sensodyne toothpaste-maker Haleon planning job cutsThe company behind the Sensodyne toothpaste and Advil painkillers was spun off from GSK last year and has more than 24,000 staff globally. ...
CCI approves BC Asia Investments' stake acquisition in IIFL Wealth ManagementBC Asia Investments X Ltd is indirectly held by Bain Capital Investors LLC (Bain Private Equity), Bain Capital Credit Member LLC and Bain C...
GSK's RSV vaccine succeeds in late-stage trial for older adultsThe RSV vaccine is a key component of the British drugmaker's plans to boost its drug development success rate as it prepares to spin off i...
Pfizer to exit GSK's consumer health arm Haleon after spin-offBefore the spinoff, the holding company for the consumer health business will pay dividends to GSK and Pfizer. That will translate to GSK r...